[5] S. Rogelj, D.F. Stern and M. Klagsbrun: Construction and Expression of a Transforming Gene Resulting From a Fusion of a Basic FGF Gene with a Signal Peptide Sequence. In: Peptide Growth Factors, Methods in Enzymology, 198, 117-124. D. Barnes, J.P. Mather and G.H. Sato, eds. Academic Press, 1991.

[4] M. Klagsbrun, P. Fanning and S. Rogelj: Ras Transformation in 3T3 cells induces fibroblast growth factor synthesis in vitro and in vivo. In: Molecular Mechanisms in Cellular Growth and Differentiation. Biomedical Sciences Symposia, 1989.

[3] S. Rogelj and M. Klagsbrun: Oncogenic Transformation by Basic Fibroblast Growth Factors. In: Paracrine and Autocrine Factors in Reproductive Endocrinology, p.19-28. Bela J. Gulyas and Lewis C. Krey, eds. Plenum Press, 1989.

[2] S. Rogelj and M. Klagsbrun: Basic Fibroblast Growth Factor Induces Tumorigenicity in Immunocompetent Animals Only After Acquiring a Signal Peptide. Progress in Endocrinology, 517-522. Imura et al., editors. Elsevier Science Publishers B.V., Biomedical Division, 1988.

[1] S. Rogelj, M.Klagsbrun and R.A. Weinberg: The Basic Fibroblast Growth Factor (bFGF) Gene Can Function as an Oncogene. Symposium on: Molecular Biology in Hematology, Trapani, Italy, 6 Sept 1987 p.67-80. (National Research Council; Italian Society for Hematology.)

[17] Rogelj S. Reiter K.J., Kesner L., Li M. and Essex D.: Enzyme Destruction by a Protease Contaminant in Bacitracin. Manuscript accepted for publication in Biochemical and Biophysical Research Communications. 6/5/2000

[16] Bennett T.A., Edwards,B.S., Sklar L.A. and Rogelj S.: Sulfhydryl Regulation of L-Selectin: Promotion of Activation Independent L-selectin Shedding from Leukocytes. Journal of Immunology 164:4120-4129 (2000)

[15] Guyer D. A., Moore K., Schammel C.M.G., Lynam E., Bennett T., Rogelj S, Edwards B.S., Mellors A., McEver R., and Sklar, L.A.: P-Selectin Glycoprotein Ligand-1(PSGL-1) is a Ligand for L-selectin in Neutrophil Aggregation. Blood; 88:(7) 2415-2421 (1996).

[14] Lynam E.B., Rogelj S., Edwards, B.S. and Sklar, L.A.: Enhanced aggregation in human neutrophils by MnCl2 or DTT differentiates the roles of L-selectin and beta2-integrins. Journal of Leukocyte Biology; 60: 356-364, (1996).

[13] Bennett T.A., E.B. Lynam, Sklar L.A. and Rogelj S.: Hydroxamate-based metalloprotease inhibitor blocks shedding of L-selectin adhesion molecule from leukocytes: functional consequences for neutrophil aggregation. Journal of Immunology; 156: 3093-3097 (1996).

[12] Bennett T.A., Schammel C.M.G., Lynam E.B., Guyer D.A., Mellors A., Edwards B., Rogelj S. and Sklar L.A.: Evidence for a third component in neutrophil aggregation: potential roles of O-linked glycoproteins as L-selectin counter-structures Journal of Leucocyte Biology, 58: 510-518 (1995).

[11] Goldstein B., Rogelj S., Siegal S., Farmer S.R., Niles R.M.: Cyclic AMP mediated induction of F9 teratocarcinoma differentiation in the absence of retinoic acid. Journal of Cellular Physiology, 143(2):205-212 (1990).

[10] W.E.Serafin, D.S.Reynolds, S.Rogelj, W.S.Lane, G.Conder, S.S.Johnson, K.F.Austen and R.L.Stevens: Identification and Molecular Cloning of a Novel Mouse Mucosal Mast Cell Serine Protease. Journal of Biological Chemistry, 265(1): 423-429 (1990)

[9] S.E. Egan, L. Jarolim, S. Rogelj, M. Spearman, J.A. Wright and A.H. Greenberg: Growth Factor Modulation of Metastatic Lung Colonization. Anticancer Research, 10: 1341-1346 (1990).

[8] N. Iberg, S. Rogelj, P. Fanning and M. Klagsbrun: Purification of 18 kDa and 22 kDa forms of basic fibroblast growth factor in cells transformed by the ras oncogene. Journal of Biological Chemistry, 264 (33): 19951-19955 (1989).

[7] S. Rogelj, M. Klagsbrun, R. Atzmon, M. Kurokawa, A.Haimovitz, Z. Fuks and I. Vlodavsky: Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC-12 cells. Journal of Cell Biology, 109: 823-831 (1989).

[6] S. Rogelj, R.A. Weinberg, P. Fanning and M. Klagsbrun: Characterization of Tumors Produced by Signal Peptide-bFGF Transformed Cells. Journal of Cellular Biochemistry, 39: 13-24 (1989).

[5] R. Hannan, S. Kourembans, K. Flanders, S. Rogelj, A. Roberts, D. Faller and M. Klagsbrun: Human Endothelial Cells Synthesize Fibroblast Growth Factor and Transforming Growth Factor Beta. Growth Factors, 1:7-17 (1988).

[4] S. Rogelj, R.A. Weinberg, P. Fanning and M. Klagsbrun: Basic Fibroblast Growth Factor (bFGF) Fused to a Signal Peptide Transforms Cells. Nature, 331(6152): 173-175 (1988).

[3] S.H. Friend, R. Bernards, S. Rogelj, R.A. Weinberg, J.M. Rappaport, D.M. Albert and T.P. Dryja: Identification of a Human DNA Segment Having Properties of the Gene that Predisposes to Retinoblastoma and Osteosarcoma. Nature, 323 (6089): 643-646 (1986).

[2] R.M. Niles, B. Loewy and S. Rogelj: The Effect of Retinoic acid on Protein Phosphorylation in Mouse Melanoma Cells. Experimental Cell Research, 164: 437-44 (1986).

[1] S. Rogelj, B. Loewy and R.M. Niles: The Effect of Retinoic Acid on Cyclic AMP Binding Proteins in Mouse Melanoma Cells. European Journal of Biochemistry, 139: 351-357 (1984).